Kelly Wang

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

John O. Link, James G. Taylor, Lianhong Xu et al. · Journal of Medicinal Chemistry · 2013 · 290 citations

Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®

James G. Taylor, Sheila Zipfel, Kyla Ramey et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 83 citations

Molecular Virology, Viral Hepatitis, Immunology +6

Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent

Raju Subramanian, Jennifer Tang, Jim Zheng et al. · Molecular Pharmaceutics · 2023 · 38 citations · Full text

Pharmaceutical Science, Pharmacokinetic Modeling, Flip-flop Kinetics +14

<i>In Vitro</i>Characterization of GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile

Christian Callebaut, Kirsten M. Stray, Luong Tsai et al. · Antimicrobial Agents and Chemotherapy · 2011 · 34 citations · Full text

Dually responsive mesoporous silica nanoparticles regulated by upper critical solution temperature polymers for intracellular drug delivery

Mingyang Hei, Jun Wang, Kelly Wang et al. · Journal of Materials Chemistry B · 2017 · 34 citations